Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction-Reference-Cited by-同舟云学术

Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction

Published:2020-11 Issue: Volume:148 Page:1-14
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Manning Janet R.,Wijeratne Aruna B.,Oloizia Brian B.,Zhang Yu,Greis Kenneth D.,Schultz Jo El J.

Funder

NIH/NHLBI

NIH

University of Cincinnati Millennium Scholars Fund

Cincinnati Children's Hospital Research Foundation

Pharmaceutical Research and Manufacturers of America

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference93 articles.

1. Fibroblast growth factor cardioprotection against ischemia-reperfusion injury may involve K+ ATP channels;Cuevas;Eur. J. Med. Res.,2000

2. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia;House;Circulation,2003

3. Basic fibroblast growth factor is cardioprotective in ischemia- reperfusion injury;Padua;Mol. Cell. Biochem.,1995

4. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts;Sheikh;Am. J. Physiol. Heart Circ. Physiol.,2001

5. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury;Liao;J. Mol. Cell. Cardiol.,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vericiguat alleviates ventricular remodeling and arrhythmias in mouse models of myocardial infarction via CaMKII signaling;Life Sciences;2023-12

2. Fibroblast growth factor receptor signaling in cardiomyocytes is protective in the acute phase following ischemia-reperfusion injury;Frontiers in Cardiovascular Medicine;2022-09-23